diagnost tool
noisi busi remain good
shape eye turn analyst day buy pt
deliv beat bottom line rais bottom line guidanc
year miss top line narrowli trim revenu guid
conclus revenu shortfal consist factor like
impact busi go forward make differ buy thesi attent
turn compani analyst day hq main attend august
think like due new product launch around
whether announc analyst day vmx remain seen reiter
buy rais pt roll forward new estim
beat bottom deliv small miss top adj ep
rep fxn beat om y/i beat
 came us disciplin expens manag low
benefit cost lpd cost control rev rep fxn miss
see shortfal rational grew y/i
match us help price increas mix benefit
revenue shortfal light rev due miss ou instrument tough
comp china china livestock rev relat african swine fever outbreak time
order uk brexit-rel due equival day impact total
sum miss speak compani convinc
impact transitori small underli growth busi intact
segment growth larg in-lin deliv segment growth larg
match estim includ report growth fxn net
global deliv fxn growth consum fxn
growth refer lab growth softwar growth rapid assay
instrument declin fxn due difficult prior year comp china-rel
gross-margin water busi healthi organ off-set lpd
fxn us key metric robust fxn consum growth
pivot buy thesi
guid carri forward ep beat rais adj ep guid
rep rep trim revenue
guid midpoint due miss worsen fx headwind
look rev rep organ idxx
initi revenue guid rep organ in-lin
prior estim go easier comp extra
busi day expect add revenue growth
model trim rev report fxn rais
adj ep y/i modestli trim
revenu ep carri rep revenu growth assumpt
slightli lower revenu base initi revenu
y/i report adj ep y/i
bull thesi big pictur intact see next page
price close busi august
global leader anim health diagnost
instrument lab test softwar sell direct
global sale rep
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ object view
compani secur subject report discuss herein
import inform pleas see import disclosur begin page document
big pictur core compon buy thesi driven multi-year
opportun grow busi ou think intern anim health
diagnost market grow current size analyst day initi
surpris anim diagnost revenu spend target billion compound-annual-growth-rate
billion led growth ou us
think could grow revenu faster year
underli pet practic growth remain solid disclos patient practic
data anim practic prepar help animalytix lead
anim health data firm call broke clinic visit growth total
visit growth note total visit grew vs
revis clinic visit grew importantli total
practic revenu grew suggest us visit bounc around
quarter-to-quart practic revenu fairli stabl rang year
suggest stabl healthi end-us anim hospit growth
near-term potenti growth driver includ limit
lack meaning competitor ou refer lab busi solid demand
lab test world-wide earli phase newer product launch integr
challeng zoetis/abaxi may allow execut even better near-
term traction new us ou sale rep push toward prevent
well test rather sickcar greater anim health dx util
result millennial-ag pet owner addit veterinarian
link note follow recent investor meet manag
link takeaway compani analyst day last august
buy unchang target price august
diagnost tool
compani report canaccord genuiti estim detail financi model includ balanc sheet incom statement cash flow project avail may obtain contact canaccord genuiti sale person author analyst whose contact
inform appear front page report
buy unchang target price august
diagnost tool
buy unchang target price august
diagnost tool
